Unipharma Products Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 24-06-2024
- Paid Up Capital ₹ 0.10 M
as on 24-06-2024
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 20.19%
(FY 2021)
- Profit 104.76%
(FY 2021)
- Ebitda 25.81%
(FY 2021)
- Net Worth 177.63%
(FY 2021)
- Total Assets 149.03%
(FY 2021)
About Unipharma Products
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rakesh Bansal and Anshit Bansal serve as directors at the Company.
- CIN/LLPIN
U74999DL2019PTC344181
- Company No.
344181
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jan 2019
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Unipharma Products?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Bansal  | Director | 10-Jan-2019 | Current |
| Anshit Bansal | Director | 10-Jan-2019 | Current |
Financial Performance of Unipharma Products.
Unipharma Products Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 20.19% increase. The company also saw a substantial improvement in profitability, with a 104.76% increase in profit. The company's net worth Soared by an impressive increase of 177.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unipharma Products?
In 2021, Unipharma Products had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bay Boutique Private LimitedActive 2 years 7 monthsRakesh Bansal and Anshit Bansal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Unipharma Products?
Unlock and access historical data on people associated with Unipharma Products, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unipharma Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unipharma Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
